Notes
The affiliations of Task Force members are listed in the Appendix. Their Disclosure forms are available on the respective society Web Sites. These guidelines also appear in the Journal of Hypertension, doi:10.1097/HJH.0b013e3281fc975a and in the European Heart Journal (2007) 28, 1462‐1536 doi:10.1093/eurheartj/ehm236
* Correspondence to Giuseppe Mancia, Clinica Medica, Ospedale San Gerardo, Universita Milano‐Bicocca, Via Pergolesi, 33 ‐ 20052 MONZA (Milano), Italy. Tel: ±39 039 233 3357; fax: ±39 039 32 22 74, e‐mail: [email protected]
* Correspondence to Guy de Backer, Dept. of Public Health, University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. Tel: ±32 9 240 3627; fax: ±32 9 240 4994; e‐mail: [email protected]
The content of these European Guidelines has been published for personal and educational use only. No commercial use is authorized. Whole or parts of the Guidelines may be translated or reproduced with permission from the ESH or the ESC.
Disclaimer. The Guidelines represent the views of the ESH and the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, however, override the individual responsibility of health professionals to make appropriate decisions in the circumstances of the individual patients, in consultation with that patient, and where appropriate and necessary the patient's guardian or carer. It is also the health professional's responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription.
© 2007 The European Society of Hypertension (ESH) and European Society of Cardiology (ESC). All rights reserved.